CI vs. MRK
Compare and contrast key facts about Cigna Corporation (CI) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CI or MRK.
Correlation
The correlation between CI and MRK is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CI vs. MRK - Performance Comparison
Loading data...
Key characteristics
CI:
-0.31
MRK:
-1.51
CI:
-0.33
MRK:
-2.07
CI:
0.96
MRK:
0.73
CI:
-0.37
MRK:
-0.93
CI:
-0.82
MRK:
-1.74
CI:
12.16%
MRK:
23.27%
CI:
27.43%
MRK:
27.72%
CI:
-84.34%
MRK:
-68.62%
CI:
-15.04%
MRK:
-42.42%
Fundamentals
CI:
$81.04B
MRK:
$192.42B
CI:
$17.93
MRK:
$6.60
CI:
16.92
MRK:
11.13
CI:
0.59
MRK:
0.70
CI:
0.32
MRK:
3.01
CI:
2.00
MRK:
3.98
CI:
$254.47B
MRK:
$63.92B
CI:
$254.47B
MRK:
$51.75B
CI:
$11.02B
MRK:
$27.30B
Returns By Period
In the year-to-date period, CI achieves a 12.40% return, which is significantly higher than MRK's -24.16% return. Over the past 10 years, CI has outperformed MRK with an annualized return of 9.61%, while MRK has yielded a comparatively lower 5.91% annualized return.
CI
12.40%
-6.02%
-3.77%
-8.48%
11.86%
9.61%
MRK
-24.16%
-4.58%
-22.68%
-41.53%
2.76%
5.91%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CI vs. MRK — Risk-Adjusted Performance Rank
CI
MRK
CI vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cigna Corporation (CI) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CI vs. MRK - Dividend Comparison
CI's dividend yield for the trailing twelve months is around 1.85%, less than MRK's 4.22% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CI Cigna Corporation | 1.85% | 2.03% | 1.64% | 1.35% | 1.74% | 0.02% | 0.02% | 0.02% | 0.02% | 0.03% | 0.03% | 0.04% |
MRK Merck & Co., Inc. | 4.22% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.42% | 3.11% |
Drawdowns
CI vs. MRK - Drawdown Comparison
The maximum CI drawdown since its inception was -84.34%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for CI and MRK. For additional features, visit the drawdowns tool.
Loading data...
Volatility
CI vs. MRK - Volatility Comparison
The current volatility for Cigna Corporation (CI) is 8.70%, while Merck & Co., Inc. (MRK) has a volatility of 12.24%. This indicates that CI experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CI vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Cigna Corporation and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CI vs. MRK - Profitability Comparison
CI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Cigna Corporation reported a gross profit of 65.50B and revenue of 65.50B. Therefore, the gross margin over that period was 100.0%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
CI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Cigna Corporation reported an operating income of 1.65B and revenue of 65.50B, resulting in an operating margin of 2.5%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
CI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Cigna Corporation reported a net income of 1.32B and revenue of 65.50B, resulting in a net margin of 2.0%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.